IP38-01: Tipifarnib Suppresses Exosome Biogenesis/Secretion in Aggressive Prostate Cancer Cells: Working Toward an Adjuvant Strategy to Overcome Enzalutamide Resistance

Saturday, May 16, 2026 1:00 PM to 3:00 PM · 1 hr. 59 min. (America/New_York)
146A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!